Connor, Clark & Lunn Investment Management (CC&L)
CRHM

Connor, Clark & Lunn Investment Management (CC&L)’s CRH Medical Corporation CRHM Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,799,417
Closed -$7.12M – 1168
2021
Q1 		$7.12M Sell
1,799,417
-353,700
-16% -$1.14M 0.04% 292
2020
Q4 		$5.04M Sell
2,153,117
-54,400
-2% -$133K 0.03% 337
2020
Q3 		$4.77M Buy
2,207,517
+109,282
+5% +$255K 0.03% 316
2020
Q2 		$4.39M Buy
2,098,235
+15,900
+0.8% +$32.1K 0.03% 320
2020
Q1 		$2.78M Sell
2,082,335
-66,200
-3% -$216K 0.03% 351
2019
Q4 		$7.46M Buy
2,148,535
+27,800
+1% +$87.7K 0.05% 222
2019
Q3 		$6.52M Buy
2,120,735
+57,959
+3% +$172K 0.04% 228
2019
Q2 		$6.22M Sell
2,062,776
-74,400
-3% -$213K 0.04% 247
2019
Q1 		$5.65M Sell
2,137,176
-64,623
-3% -$199K 0.04% 264
2018
Q4 		$6.74M Buy
2,201,799
+392,900
+22% +$1.29M 0.05% 224
2018
Q3 		$7.19M Buy
1,808,899
+1,217,234
+206% +$4.49M 0.04% 256
2018
Q2 		$1.85M Buy
591,665
+546,900
+1,222% +$1.74M 0.01% 494
2018
Q1 		$113K Buy
+44,765
New +$126K ﹤0.01% 686
2017
Q4 		– Sell
-383,542
Closed -$997K – 888
2017
Q3 		$997K Sell
383,542
-1,234,238
-76% -$3.79M 0.01% 532
2017
Q2 		$9.19M Sell
1,617,780
-265,844
-14% -$1.73M 0.06% 193
2017
Q1 		$15.4M Buy
1,883,624
+1,066,930
+131% +$7.38M 0.1% 138
2016
Q4 		$4.37M Buy
816,694
+125,994
+18% +$639K 0.03% 267
2016
Q3 		$2.67M Buy
690,700
+451,500
+189% +$1.73M 0.02% 321
2016
Q2 		$926K Buy
+239,200
New +$782K 0.01% 480

Connor, Clark & Lunn Investment Management (CC&L)'s CRHM Position: Q2 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 1,799,417 shares — an estimated $7.12M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CRHM in Q2 2016 and held it in 19 quarters. The position peaked at $15.4M in Q1 2017. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,799,417 CRH Medical Corporation shares in Q2 2021, an estimated $7.12M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CRH Medical Corporation in Q2 2016 and held it in 19 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s CRH Medical Corporation position peaked at $15.4M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2021, filed 12 Aug 2021.